India's unending price cap tussle: essential meds vs shortages
This article was originally published in Scrip
Executive Summary
"Don't kill the goose that lays the golden egg." This is what industry's retort appears to be to an Indian parliamentary committee report that expressed "surprise" that all drugs are not listed on the country' s national list of essential medicines (NLEM) - implying that the panel favours price caps across the board.